United Therapeutics Quarterly Earnings Report Released

United Therapeutics, a pharmaceutical company, has published its quarterly financial statement for the period ending [insert date]. Key highlights from the report include:

• The company’s stock price has fluctuated over the past year, with a 52-week high of $417.82 reached in November 2024 and a low of $266.98 in April 2025.
• The stock closed at $313.13 on the last trading day.
• The company’s financial metrics are as follows:
  • Price-to-earnings ratio: 12.22
  • Price-to-book ratio: 1.97